A Research Study Looking at New Protein-based Tablets in Healthy Men - Oral Formulation II

NCT05333107 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

152

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Volunteers; High Cholesterol

Interventions

DRUG: NNC0385-0434 G
DRUG: NNC0385-0434 F
DRUG: NNC0385-0434 B

Sponsor

Novo Nordisk A/S